M&A Deal Summary

Toyoda Gosei Acquires Craif

On March 4, 2024, Toyoda Gosei acquired life science company Craif

Acquisition Highlights
  • This is Toyoda Gosei’s 1st transaction in the Life Science sector.
  • This is Toyoda Gosei’s 5th transaction in Japan.

M&A Deal Summary
Date 2024-03-04
Target Craif
Sector Life Science
Buyer(s) Toyoda Gosei
Deal Type Add-on Acquisition

Target

Craif

Tokyo, Japan
website
Craif develops and sells test kits that can easily and highly sensitively detect the risks of seven types of cancer, including pancreatic and lung cancer, as early as cancer stage 1. These kits comprehensively and efficiently capture and measure small microRNA molecules called miRNA2 in urine, which are generally difficult to detect. Craif is based in Tokyo.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Toyoda Gosei

Kiyosu, Japan

website

Category Company
Founded 1949
Sector Automotive
Employees39,511
Revenue 830.2B JPY (2022)
DESCRIPTION

Toyoda Gosei Co. is a specialty manufacturer of rubber and plastic automotive parts. Today, the Toyoda Gosei Group provides a variety of high-quality products internationally, with a network of approximately 100 plants and offices in 18 countries and regions. Through its flexible, integrated global supply system and leading-edge technologies, Toyoda Gosei aims to grow as a global company that acts flexibly and swiftly in today’s dramatically changing business environment, delivering the highest levels of satisfaction to customers worldwide through safety, comfort, well-being and the environment. Toyoda Gosei was founded in 1949 and is based in Kiyosu, Japan.

DEAL STATS #
Overall 5 of 5
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 4
Country (Japan) 5 of 5
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-28 ThinkCyte

Tokyo, Japan

ThinkCyte is focused on developing and commercializing cell analysis and sorting technology platform using AI-based cell image analysis. Its technology to analyze individual cells and sort them will enable faster and more accurate diagnoses than conventional methods. ThinkCyte was formed in 2016 and is based in Tokyo.

Buy -
Mergr

Product

Company

Legal